Pharvaris (PHVS) Depreciation and Depletion (2020 - 2026)

Pharvaris (PHVS) posted Depreciation and Depletion of $122607.5 for Q1 2026, little changed on a QoQ basis from $122070.9 in Q4 2025, and up 10.69% year-over-year from $110764.5 in Q1 2025.

Pharvaris (PHVS) Depreciation and Depletion (2020 - 2026) Analysis & Trends

Pharvaris' Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $122607.5 for Q1 2026.

  • Quarterly Depreciation and Depletion rose 10.69% year-over-year to $122607.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $484235.0 (up 46.84% YoY) and the FY2025 annual result came in at $472659.9, up 62.0% from the prior year.
  • Depreciation and Depletion was $122607.5 for Q1 2026 at Pharvaris, roughly flat from $122070.9 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $134.6 billion in Q2 2023 and bottomed at -$134.5 billion in Q3 2023.
  • A 5-year average of $2.5 million and a median of $72085.5 in 2024 frame the typical range for Depreciation and Depletion.
  • Peak annual rise in Depreciation and Depletion reached 356841850.47% in 2023, while the deepest fall reached 345944944.87% in 2023.
  • Pharvaris' Depreciation and Depletion stood at $47108.9 in 2022, then jumped by 50.8% to $71038.9 in 2023, then soared by 36.82% to $97197.3 in 2024, then rose by 25.59% to $122070.9 in 2025, then increased by 0.44% to $122607.5 in 2026.
  • Business Quant data shows PHVS's Depreciation and Depletion at $122607.5 in Q1 2026, $122070.9 in Q4 2025, and $122928.5 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 39.39 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Pharvaris 2.17 Bn 1.88 Bn - 122,607.51

Historic Data

Download Data
DateValue
Mar 31, 2026 122,607.51
Mar 31, 2026 122,607.51
Dec 31, 2025 122,070.92
Dec 31, 2025 122,070.92
Sep 30, 2025 122,928.48
Sep 30, 2025 122,928.48
Jun 30, 2025 116,628.07
Jun 30, 2025 116,628.07
Mar 31, 2025 110,764.48
Mar 31, 2025 110,764.48
Dec 31, 2024 97,197.30
Dec 31, 2024 97,197.30
Sep 30, 2024 47,851.62
Sep 30, 2024 47,851.62
Jun 30, 2024 73,957.41
Jun 30, 2024 73,957.41
Mar 31, 2024 72,085.54
Mar 31, 2024 72,085.54
Dec 31, 2023 71,038.93
Dec 31, 2023 71,038.93